HERAN Partners

HERAN Partners is a Belgium-based venture capital firm committed to creating transformative impact within the healthcare and life sciences industry. The firm provides venture and growth capital, accompanied by a strong network, expertise, and mentorship, to startups and scale-ups with solid technology platforms and strong market potential. Their investment philosophy centers around addressing emerging health challenges such as an aging population, the surge in chronic diseases, and the associated increase in healthcare costs. They focus on solutions that are solving unmet needs in the market.

The firm's investment approach is built upon three strategic pillars centered around enabling technologies: MedTech, HealthTech, and Digital Health. In MedTech, they invest in creating efficiencies through lab equipment and services, diagnostic analysis platforms, and multi-omics technologies. In HealthTech, they leverage software and data to create innovative solutions. In Digital Health, they focus on the integration of technology into healthcare services to improve patient outcomes and operational efficiencies.

HERAN Partners has an impressive track record of investments in various companies. Notably, they co-led a €5 million seed investment in Nuclivision, a Belgian company developing AI-driven software solutions for nuclear medicine applications. They also invested in Amaron, a Belgian healthcare IT company specializing in data exchange platforms for hospitals. Additionally, they have invested in Gynaia, a women's health diagnostics company, and Nuclivision, a developer of software solutions for nuclear imaging. These investments reflect their commitment to supporting innovative companies that aim to have a transformative impact on healthcare and life sciences.